HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A functionalized 20-residue peptaibol derivative for nucleic acid delivery.

Abstract
Based on the membrane-modifying peptaibol trichocellin-A-I (1) from Trichoderma viride, we designed a vehicle for the cellular delivery of antisense oligodeoxynucleotides by attaching a (Lys)10 stretch to the C-terminus of 1. The resulting transporter peptide 2, prepared by solid-phase synthesis using Fmoc protocol in combination with amino acid fluorides, was found to be mainly alpha-helical in solution, in contrast to its precursors 1 and 3. The uptake of the complex formed between carrier 2 and a fluorescence-tagged oligonucleotide, i.e., 4, was studied at different charge ratios by confocal laser-scanning microscopy, using two different eukaryotic cell lines: mouse embryonal fibroblast (NIH3T3) and human lung carcinoma (A549) cells. Peptide 2 readily translocated 4 into the cytoplasms of NIH3T3 cells. However, the peptide/oligonucleotide complex was accumulated around the plasma membrane of the A549 cells.
AuthorsShun-ichi Wada, Reiko Tanaka
JournalChemistry & biodiversity (Chem Biodivers) Vol. 4 Issue 5 Pg. 991-7 (May 2007) ISSN: 1612-1880 [Electronic] Switzerland
PMID17510994 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Drug Carriers
  • Nucleic Acids
  • Peptaibols
  • Peptides
  • trichocellin
Topics
  • 3T3 Cells
  • Animals
  • Biological Transport (physiology)
  • Cell Proliferation (drug effects)
  • Drug Carriers (chemistry)
  • Drug Delivery Systems
  • Fibroblasts (metabolism)
  • Humans
  • Mice
  • Nucleic Acids (administration & dosage)
  • Peptaibols
  • Peptides (chemistry)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: